Wakix
Chemical Name | pitolisant |
Dosage Form | Tablet (oral; 4.45 mg, 17.8 mg) |
Drug Class | Receptor antagonists |
System | Nervous |
Company | Harmony Biosciences |
Approval Year | 2019 |
Indication
- Wakix is indicated for the treatment of excessive daytime sleepiness (EDS) in adult patients with narcolepsy.